Inactive Instrument

BioTelemetry, Inc.

Equities

BEAT

US0906721065

Healthcare Facilities & Services

BioTelemetry, Inc. and Wellbridge Health, Inc. Announce Strategic Alliance

January 06, 2014 at 01:01 pm

BioTelemetry, Inc. and Well Bridge Health, Inc. announced the formation of a partnership to commercialize a novel approach to the management and remote monitoring of CHF patients. BioTelemetry has provided Wellbridge Health initial funding in the form of a convertible note.

Latest news about BioTelemetry, Inc.

Ayala Pharmaceuticals, Inc. announced that it has received $2 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	02-29	CI
Ayala Pharmaceuticals, Inc. announced that it has received $4 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	11-16	CI
Ayala Pharmaceuticals, Inc. entered into a definitive merger agreement to acquire BioSight Ltd from Israel Biotech Fund, BioTelemetry, Inc., Arkin Bio Venture Partners Ltd., Primera Capital, SBI JI Innovation Advisory Ltd., Migdal Insurance Company Ltd., The Phoenix Insurance Company Ltd. and others.	26/07/23	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Health Care Services Select Industry Index	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Composite 1500	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care Services (Sub Ind)	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 1000	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P TMI Index	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Global BMI Index	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care	10/02/21	CI
BioTelemetry, Inc. Announces Board Changes	09/02/21	CI
BioTelemetry, Inc. Terminates Amended and Restated Credit Agreement	09/02/21	CI
Koninklijke Philips N : Royal Philips Completes Tender Offer to Acquire BioTelemetry at $72 per Share	09/02/21	MT
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from NASDAQ Composite Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Growth-Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Growth-Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Dynamic Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 3000 Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2500 Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Growth Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Completeness Index	09/02/21	CI

Chart BioTelemetry, Inc.

Duration

Period

More charts

Company Profile

BioTelemetry, Inc. is a remote medical technology company focused on delivery of health information. The Company is principally engaged in providing remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. The Company operates in two segments: Healthcare and Research. The Healthcare segment is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices. It offers cardiologists, electrophysiologists and primary care physicians a full spectrum of solutions, which provides them with a single source of cardiac monitoring services. The Research segment is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+19.32%	83.53B
CVS HEALTH CORPORATION	-21.99%	75.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	26.73B
LABCORP HOLDINGS INC.	-5.06%	18.25B
FRESENIUS SE & CO. KGAA	+6.95%	18.12B
QUEST DIAGNOSTICS INCORPORATED	+7.69%	16.51B
NATERA, INC.	+76.20%	14.05B
TENET HEALTHCARE CORPORATION	+76.56%	13.03B
PURE HEALTH HOLDING	-27.89%	12.67B

Other Healthcare Facilities & Services